Results 101 to 110 of about 10,485 (198)

Anabolic treatment for osteoporosis: teriparatide

open access: yes, 2017
Teriparatide is a safe and effective anabolic treatment for osteoporosis. In postmenopausal women, it increases BMD and decreases vertebral fractures by about 70% and non-vertebral fractures by about 45% (although there is no evidence that it prevents ...
R Eastell, Eastell, R., Walsh, J.S.
core   +1 more source

Head-to-head comparisons of bisphosphonates and teriparatide in osteoporosis: a meta-analysis

open access: yes, 2017
Purpose: This meta-analysis aimed to compare the efficacy and safety of teriparatide vs. bisphosphonates in the management of osteoporosis. Methods: A total of 1,967 patients from eight randomized controlled trials were analyzed; outcomes included bone ...
Cho, Der-Yang   +3 more
core   +2 more sources

Transient severe hypotension with once-weekly subcutaneous injection of teriparatide in osteoporotic patient : a case report and insight for the drug interaction between hypotensive agents and teriparatide [PDF]

open access: yes, 2015
Teriparatide, a recombinant form of parathyroid hormone, were well recognized as a useful option for the treatment of the osteoporosis. Although some side effects of teriparatide include headache, nausea, dizziness, and limb pain were reported.
294055/profile-ja.html   +35 more
core  

Persistence with teriparatide in patients with osteoporosis: the UK experience

open access: yes, 2006
INTRODUCTION: The objective of this paper was to determine the persistence with teriparatide at 12 months in all patients in the UK who were prescribed the treatment since its launch.
Arden, N.K.   +11 more
core   +1 more source

Teriparatide and fracture healing [PDF]

open access: yes
Background: Ankle fractures are common injuries especially in the elderly that can cause morbidity. There is some evidence that Teriparatide, a drug used to treat osteoporosis, may accelerate fracture healing.
Alshaikh, Adel
core  

Revealing the therapeutic potential of teriparatide: a review

open access: yes
Teriparatide is an FDA-approved medication for osteoporosis that presents promising results in treating various musculoskeletal conditions. It helps in improving the bone mineral density and preventing fractures in individuals with osteoporosis.
Kundnani, Vishal   +3 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Low Rate of Teriparatide Supplementation for the Treatment of Osteoporotic Pelvic Fractures in Elderly Females

open access: yesGeriatric Orthopaedic Surgery & Rehabilitation
Background Osteoporotic pelvic fractures in the elderly lead to pain and immobility resulting in decreased quality of life and worsening frailty. Teriparatide has been shown to shorten time to fracture union, diminish pain, and improve mobilization.
David Novikov MD   +3 more
doaj   +1 more source

Effects of Teriparatide in Bone Cells

open access: yes, 2013
Astronauts in prolonged space flight and bedridden patients experience bone density loss due to a lack of mechanical stimuli. The mechanisms by which cells transduce physical stimuli to chemical signals are poorly understood.
Mather, Kellen   +6 more
core  

Efficacy of once-weekly teriparatide versus alendronate in Chinese postmenopausal osteoporosis: a randomised, open-label, active-controlled, 48-week, multicentre phase III study. [PDF]

open access: yesJ Orthop Translat
Gu J   +41 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy